Head and neck cancer is a common yet aggressive malignancy with a poor prognosis, particularly when diagnosed at advanced stages. Despite progress in surgical, chemotherapeutic, and radiotherapeutic interventions, overall disease control and patient survival rates remains low due to high rates of recurrence and therapeutic resistance. Head and neck cancer continues to be a challenging disease and many efforts across the world are in process to help diagnose, treat, manage and surveil this disease and the patients it affects. Advances in therapeutics and new technologies continue to be developed and utilized in management of this challenging disease. Neoadjuvant and adjuvant immunotherapy prior to standard of care treatment has shown promising advances in response and overall control of disease in both mucosal, cutaneous and endocrine cancers. Artificial intelligence technology is opening new opportunities for complex data analysis and advances in translational and clinical care of patients. Advances in optical imaging technology is helping identification of cancer. Novel approaches to surgical planning and treatment are extending treatment possibilities with less morbidity and improved outcomes. This panel of experts will discuss new technologies, advances and treatment strategies in head & neck cancer. Speakers and panel discussion will focus and update on important topics in head and neck cancer:

Faculty Roster for Head & Neck Oncology American Academy of Otolaryngology Panel Symposia:

Wojciech Mydlarz MD

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University School of Medicine

Clint Allen MD

Center for Cancer Research/National Cancer Institute

National Institute of Health

Nicole Schmitt MD

Winship Cancer Institute

Emory University School of Medicine

Steven Chinn MD, MPH

Hillman Cancer Center

University of Pittsburgh Medical Center

Mark Zafereo MD

University of Texas MD Anderson Cancer Center

Jaime Ku MD

Head and Neck Institute

Cleveland Clinic 

Eleni Rettig MD

Brigham and Women's Hospital/Dana-Farber Cancer Institute

Harvard Medical School

Melina Windon MD

Markey Cancer Center

University of Kentucky School of Medicine

- Advances in head and neck cancer detection, and surveillance

- Advances and management updates in head and neck cancer

- Novel approaches open and endoscopic approaches to head and neck tumors

- Targeted therapy and immunotherapy combined with surgery for advanced thyroid cancer

- Translation applications of Artificial Intelligence in head and neck cancer